We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$241B
AUM Growth
+$7.57B
Cap. Flow
+$8.13B
Cap. Flow %
3.37%
Top 10 Hldgs %
21.84%
Holding
2,809
New
56
Increased
1,358
Reduced
887
Closed
62

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$948M
2
SNOW icon
Snowflake
SNOW
+$542M
3
SE icon
Sea Limited
SE
+$501M
4
PG icon
Procter & Gamble
PG
+$491M
5
SNAP icon
Snap
SNAP
+$403M

Sector Composition

Rank Sector Weight
1 Technology 26.21%
2 Healthcare 13.25%
3 Financials 13.07%
4 Consumer Discretionary 12.28%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
2526
UroGen Pharma
URGN
$1.97B
$377K ﹤0.01%
22,400
APLT
2527
DELISTED
Applied Therapeutics
APLT
$377K ﹤0.01%
22,695
LPG icon
2528
Dorian LPG
LPG
$1.96B
$373K ﹤0.01%
30,065
ICPT
2529
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$373K ﹤0.01%
25,109
UVE icon
2530
Universal Insurance Holdings
UVE
$1.26B
$370K ﹤0.01%
28,342
FLXN
2531
DELISTED
Flexion Therapeutics, Inc.
FLXN
$368K ﹤0.01%
60,406
ECVT icon
2532
Ecovyst
ECVT
$1.32B
$367K ﹤0.01%
31,509
KODK icon
2533
Kodak
KODK
$809M
$365K ﹤0.01%
53,537
-10,075
-16% -$73.5K
BOC icon
2534
Boston Omaha
BOC
$436M
$365K ﹤0.01%
9,400
ARD
2535
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$362K ﹤0.01%
14,185
HA
2536
DELISTED
Hawaiian Holdings, Inc.
HA
$361K ﹤0.01%
16,656
DHT icon
2537
DHT Holdings
DHT
$2.99B
$357K ﹤0.01%
+54,600
New +$316K
CVM icon
2538
CEL-SCI Corp
CVM
$19.9M
$356K ﹤0.01%
1,081
CGEN icon
2539
Compugen
CGEN
$212M
$350K ﹤0.01%
58,650
BNFT
2540
DELISTED
Benefitfocus, Inc.
BNFT
$346K ﹤0.01%
31,206
+18,082
+138% +$220K
SPPI
2541
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$346K ﹤0.01%
158,669
PGC icon
2542
Peapack-Gladstone Financial
PGC
$815M
$341K ﹤0.01%
10,225
CRNX icon
2543
Crinetics Pharmaceuticals
CRNX
$8.88B
$340K ﹤0.01%
16,140
SP
2544
DELISTED
SP Plus Corporation
SP
$333K ﹤0.01%
10,857
HY icon
2545
Hyster-Yale Materials Handling
HY
$576M
$332K ﹤0.01%
6,611
-2,837
-30% -$174K
FMTX
2546
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$332K ﹤0.01%
14,300
EGLX
2547
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$330K ﹤0.01%
91,500
RYTM icon
2548
Rhythm Pharmaceuticals
RYTM
$7.31B
$329K ﹤0.01%
25,215
BDSI
2549
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$329K ﹤0.01%
91,129
BMRC icon
2550
Bank of Marin Bancorp
BMRC
$460M
$328K ﹤0.01%
8,690
+402
+5% +$14K

Similar funds

UBS AM's Q3 2021 Portfolio in Review

As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.

  • UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
  • UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
  • UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
  • UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
  • UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
  • UBS AM opened 56 new positions and closed 62 in Q3 2021.
  • UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.

Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.